Form 4: CVS Health Director Roger Farah Reports Stock Transactions

CVS Health director Roger Farah reported the acquisition of 50,125 restricted stock units and the disposal of 4,124.4534 common stock shares.

Summary

• Director Roger Farah of CVS Health Corp. reported a transaction on November 30, 2024.
• He acquired 50,125 restricted stock units at a price of $59.85 per unit.
• These restricted stock units will vest in two equal installments starting November 30, 2025.
• He also disposed of 4,124.4534 shares of common stock.
• Additionally, he holds 36,383.696 deferred stock units, each convertible into one share of common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by a company director, which is neither positive nor negative in itself.

Future Outlook

The restricted stock units will vest in two equal installments starting November 30, 2025.

Industry Context

This is a routine filing for a director's stock transactions, which is common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders in the US, as mandated by the SEC.
• The transactions are typical for executive compensation and stock ownership plans.
• Similar filings are made by directors and officers of other large public companies such as Walgreens Boots Alliance (WBA) and UnitedHealth Group (UNH).

Stakeholder Impact

• The transactions provide transparency to shareholders regarding the stock activities of company directors.
• The vesting of restricted stock units aligns the director's interests with the long-term performance of the company.

Key Dates

Keywords

CVS Health, stock transaction, restricted stock units, deferred stock units, director, Roger Farah, insider trading